Daniel Speidel

Company: Breakpoint Therapeutics

Job title: Managing Director & Co-Founder

Seminars:

Closing Panel Discussion: Future Directions for DDRi 5:30 pm

What is the current status of DDRi combination with IO Thoughts and rationalizing on potential best outcomes DDR-DDR combos Reviewing the various combination approaches and new targets coming in – thought experiment based on pathway What are the combinations and new targets that are going to push the field forward in a durable and effective…Read more

day: Day Two